Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min J Joo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
COPD|April 9, 2009
Medication use patterns associated with spirometry in diagnosing COPDMin J Joo, Todd A Lee, David H Au, et al.
Lung|May 9, 2008
Patterns of healthcare utilization by COPD severity: a pilot studyMin J Joo, Todd A Lee, Brian Bartle, et al.
The Annals of Pharmacotherapy|July 6, 2017
Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β<sub>2</sub>-Agonist Combined With a Long-Acting Muscarinic or Inhaled CorticosteroidJennifer C Samp, Min J Joo, Glen T Schumock, et al.
The American Journal of Geriatric Pharmacotherapy|January 28, 2012
Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patientsCaitlyn T Solem, Todd A Lee, Min J Joo, et al.
Pharmacotherapy|February 23, 2017
Comparative Effectiveness of Long-Acting Beta<sub>2</sub> -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary DiseaseJennifer C Samp, Min J Joo, Glen T Schumock, et al.
Drug Safety|June 14, 2011
Association between leukotriene-modifying agents and suicide: what is the evidence?Glen T Schumock, Todd A Lee, Min J Joo, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 13, 2026
Determinants of Medication Nonadherence Among Diverse Adults With Chronic Obstructive Pulmonary DiseaseStephanie L LaBedz, Ebere M Okpara, Archit V Potharazu, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2012
Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control studyGlen T Schumock, Leslie T Stayner, Robert J Valuck, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Predicting Acute Exacerbations in Chronic Obstructive Pulmonary DiseaseJennifer C Samp, Min J Joo, Glen T Schumock, et al.
Drug, Healthcare and Patient Safety|November 3, 2011
Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the USGlen T Schumock, Robert D Gibbons, Todd A Lee, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
COPD|April 9, 2009
Medication use patterns associated with spirometry in diagnosing COPDMin J Joo, Todd A Lee, David H Au, et al.
Lung|May 9, 2008
Patterns of healthcare utilization by COPD severity: a pilot studyMin J Joo, Todd A Lee, Brian Bartle, et al.
The Annals of Pharmacotherapy|July 6, 2017
Risk of Cardiovascular and Cerebrovascular Events in COPD Patients Treated With Long-Acting β<sub>2</sub>-Agonist Combined With a Long-Acting Muscarinic or Inhaled CorticosteroidJennifer C Samp, Min J Joo, Glen T Schumock, et al.
The American Journal of Geriatric Pharmacotherapy|January 28, 2012
Complexity of medication use in newly diagnosed chronic obstructive pulmonary disease patientsCaitlyn T Solem, Todd A Lee, Min J Joo, et al.
Pharmacotherapy|February 23, 2017
Comparative Effectiveness of Long-Acting Beta<sub>2</sub> -Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary DiseaseJennifer C Samp, Min J Joo, Glen T Schumock, et al.
Drug Safety|June 14, 2011
Association between leukotriene-modifying agents and suicide: what is the evidence?Glen T Schumock, Todd A Lee, Min J Joo, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|January 13, 2026
Determinants of Medication Nonadherence Among Diverse Adults With Chronic Obstructive Pulmonary DiseaseStephanie L LaBedz, Ebere M Okpara, Archit V Potharazu, et al.
The Journal of Allergy and Clinical Immunology|June 16, 2012
Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case-control studyGlen T Schumock, Leslie T Stayner, Robert J Valuck, et al.
Journal of Managed Care & Specialty Pharmacy|February 28, 2018
Predicting Acute Exacerbations in Chronic Obstructive Pulmonary DiseaseJennifer C Samp, Min J Joo, Glen T Schumock, et al.
Drug, Healthcare and Patient Safety|November 3, 2011
Relationship between leukotriene-modifying agent prescriptions dispensed and rate of suicide deaths by county in the USGlen T Schumock, Robert D Gibbons, Todd A Lee, et al.
Pageof 3